Atherothrombotic residual risk in coronary and peripheral artery disease patients on guideline-recommended antiplatelet monotherapy: baseline preliminary results from the RESRISK study
27 August 2021 (08:00 - 20:00)
Organised by:
Abstract
Slides
About the speaker
University of Seville, Seville (Spain)
224 More presentations in this session
Doctor B. Keskin Meric (London, GB)
Doctor R. Ong (Makati, PH)
Mr R. Gascuena (Leganes, ES)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August 2021
08:00 CET
